Healthcare -
Biotechnology - NASDAQ - US
$ 0.7132
1.86 %
$ 36.9 M
Market Cap
-1.04
P/E
XLO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities XLO - Xilio Therapeutics, Inc.
-36 K
LAST VALUE
86.11%
2 YEAR CAGR
45.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR